Delaneyshort2184

Healthcare providers caring for patients undergoing intensive oncologic care may experience challenges related to psychosocial barriers to care, which can negatively affect access to treatment and health outcomes. Recognizing and responding to these barriers caused by the experience of adversity and trauma are important considerations to ensure safe and effective patient care. The objective of this article is to demonstrate how a trauma-informed approach can be used to develop supportive interventions. Consideration of this approach not only ensures high-quality patient care, but also promotes health equity by navigating the difficult barriers that may have prevented access to care.

Chronic cough is a demanding symptom of lung cancer. Clinical research tends to underestimate the impact of lung cancer-related cough on patient quality of life. Current guidelines do not describe how oncology nurses, as a vital part of the interprofessional team, can use nonpharmacologic interventions described by behavioral cough suppression therapy (BCST) techniques for patients with lung cancer.

This article aims to provide oncology nurses with insight into BCST and investigates how to integrate BCST into lung cancer care.

A literature search for primary articles related to BCST was conducted using the electronic databases PubMed® and CINAHL®. The 2017 American College of Chest Physicians' guideline and expert panel report served as a major resource.

Oncology nurses can investigate the use of BCST techniques for patients with lung cancer with chronic cough as a nonpharmacologic intervention. Assessment of patients with chronic cough should be carried out before initiating referral for BCST, including identifying cough triggers, causes of cough, and cough types.

Oncology nurses can investigate the use of BCST techniques for patients with lung cancer with chronic cough as a nonpharmacologic intervention. Assessment of patients with chronic cough should be carried out before initiating referral for BCST, including identifying cough triggers, causes of cough, and cough types.On a high-volume academic ambulatory chemotherapy unit, a medication error triggered an evidence-based practice nursing work group to initiate a pilot "chemo checker" role as part of a new chemotherapy verification process. The group implemented two interventions to minimize nurse distractions and a 17-point chemotherapy verification label. An independent verification role was created to perform the first check for chemotherapy. Six months into the pilot project, medication administration errors and nurses' distractions during the chemotherapy verification process decreased, and nurses' perception of safety during the process increased (N = 22).

Patients with breast cancer receiving chemotherapy can experience chemotherapy-related cognitive impairment (CRCI).

This study observed the interventional effects of multisensory stimulation training on CRCI in patients with breast cancer receiving chemotherapy.

Eighty patients with breast cancer receiving chemotherapy at a grade A tertiary hospital in Tangshan City, Hebei Province, China, were divided into two intervention groups (audiovisual and multisensory) by random sampling (40 patients per group).

After four intervention cycles, participants' cognitive and executive function scores were higher in the multisensory group than in the audiovisual group. Multisensory stimulation training had stronger effects than audiovisual training and effectively attenuated CRCI and executive dysfunction caused by breast cancer chemotherapy. Given the convenience and ease of use, multisensory stimulation has good potential for application in clinical practice.

After four intervention cycles, participants' cognitive and executive function scores were higher in the multisensory group than in the audiovisual group. Multisensory stimulation training had stronger effects than audiovisual training and effectively attenuated CRCI and executive dysfunction caused by breast cancer chemotherapy. Given the convenience and ease of use, multisensory stimulation has good potential for application in clinical practice.

Immune checkpoint inhibitor (ICI) therapy is an effective treatment for many patients. Although rare, immune-mediated cardiovascular adverse events can occur, including myocarditis.

This article provides an overview of the incidence, proposed pathophysiology, and current surveillance for myocarditis in patients receiving ICI therapy.

A literature search was conducted using PubMed®, CINAHL®, and Scopus® for articles published from 2016 through 2021 to evaluate current recognition, surveillance, and management protocols for ICI-related myocarditis. Dactolisib A case study illustrates the challenges in managing patients experiencing ICI-related cardiac adverse events.

The incidence of myocarditis in patients treated with ICI therapy is 0.04%-1.14%, but it carries a high mortality rate of 25%-50%. A baseline cardiac evaluation and scheduled surveillance throughout therapy is recommended, particularly for patients with cardiovascular risk factors. Through continuing education and proper training, clinicians and nursing staff can recognize and promptly diagnose immune-related cardiac adverse events.

The incidence of myocarditis in patients treated with ICI therapy is 0.04%-1.14%, but it carries a high mortality rate of 25%-50%. A baseline cardiac evaluation and scheduled surveillance throughout therapy is recommended, particularly for patients with cardiovascular risk factors. Through continuing education and proper training, clinicians and nursing staff can recognize and promptly diagnose immune-related cardiac adverse events.

Cancer prevalence and the incidence of cancer pain are increasing. Although individualized care plans have been proposed to help manage cancer pain, minimal research has evaluated their effectiveness.

This quality improvement project assessed whether an education session on pain management guidelines from the Centers for Medicare and Medicaid Services Oncology Care Model (OCM) increased provider use of care plans and pain management options and patient satisfaction.

A pre-/postintervention analysis was performed in an outpatient oncology clinic with patients reporting cancer pain. Staff received an education session on the OCM. Quizzes documented staff knowledge, and chart reviews documented use of care plans and pain management options. Patients' pain management satisfaction was assessed via survey.

There was no significant increase in provider use of pain management care plans, and patients' pain scores increased in the postintervention period. These findings likely were affected by the COVID-19 pandemic. However, patients' pain management satisfaction scores and provider use of nonpharmacologic treatment options increased postintervention.

There was no significant increase in provider use of pain management care plans, and patients' pain scores increased in the postintervention period. These findings likely were affected by the COVID-19 pandemic. However, patients' pain management satisfaction scores and provider use of nonpharmacologic treatment options increased postintervention.

Taxane drugs frequently produce peripheral neuropathy (PN). Cold therapy to hands and feet during chemotherapy has been effective in reducing PN.

The purpose was to compare the frequency and severity of PN and quality of life in patients with breast cancer receiving cold therapy to their hands and feet versus standard of care during 12 weekly paclitaxel infusions with a follow-up at 16 weeks.

Forty-eight female participants were consecutively recruited and randomized to treatment versus control groups. This randomized control trial used the Common Terminology Criteria for Adverse Events and the Functional Assessment of Cancer Therapy-Taxane questionnaires to collect data weekly for 12 weeks and at 16 weeks.

A repeated-measures ordinal logistic model and binomial logistic model showed that patients on standard therapy were three times more likely to develop PN, with a progression toward severe PN, when compared to patients who were on cold therapy. There was no effect of treatment on quality of life.

A repeated-measures ordinal logistic model and binomial logistic model showed that patients on standard therapy were three times more likely to develop PN, with a progression toward severe PN, when compared to patients who were on cold therapy. There was no effect of treatment on quality of life.

Nationally, patients with cancer experience high numbers of emergency department (ED) visits. Many ED visits may be prevented using cancer-specific urgent care services.

The purpose of this quality improvement initiative was to first assess the reasons that adult patients with cancer used the ED instead of an urgent care clinic for cancer (UCC-C). Second, an education program was developed and implemented to improve UCC-C use.

Using semistructured interviews pre- and postintervention (education program about ED/UCC-C use), this project described knowledge of adult patients with cancer about using the ED instead of the UCC-C. The project also evaluated the efficacy of the education intervention.

Pre- to postimplementation change showed an increase in patient UCC-C knowledge, patients who said they would present to the UCC-C, and patients who presented to the UCC-C for treatment. In addition, there was a decrease in adult patients with cancer who presented to the ED and were subsequently hospitalized.

Pre- to postimplementation change showed an increase in patient UCC-C knowledge, patients who said they would present to the UCC-C, and patients who presented to the UCC-C for treatment. In addition, there was a decrease in adult patients with cancer who presented to the ED and were subsequently hospitalized.Radiation therapy has been used as a method to treat cancer since the early 1900s (Gianfaldoni et al., 2017). As of 2020, radiation continues to be a common treatment modality received by 50%-70% of patients with cancer at some point during the course of treatment (Peng et al., 2020). Numerous advances in radiation technology have occurred since its initial discovery, yet the goal of radiation remains the same. While chemotherapy is a systemic treatment, radiation therapy is designed to locally treat a malignancy. Unlike chemotherapy, radiation uses high-energy photon beams (x-ray or gamma rays), or charged particles (electrons or protons), to target specific locations of the body (Gianfaldoni et al., 2017). The damage to the DNA of the cells in the targeted region leads to eventual cell death, while allowing healthy cells outside of the targeted field to remain unaffected. Although toxicities occur, patients often experience fewer side effects during radiation therapy compared to chemotherapy because of its targeted approach. Advances in technology have led to better opportunities for targeting smaller areas of the body, reducing the potential for side effects (Garibaldi et al., 2017). In addition, radiation can be divided into larger doses to be given once a day, or less often, and is sometimes used as a shorter course of treatment. This is known as hypofractionated radiation. This article will explain the differences in radiation therapy modalities, focusing on hypofractionation and its benefits to patients.